Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Prostate cancer blood tests ‘can lead to men being over-tested’, experts say - The PSA test measures the amount of a protein made by prostate gland cells and can indicate cancer.

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Ensure accurate PSA test results with these 9 tips. Learn what to do before a PSA test to improve reliability, including managing medications, exercise, and more.

A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may ...

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...

One in eight men in the US will be diagnosed with prostate cancer, and one in 44 will die from it.Composite: The Guardian/Getty Images “You will feel a little pressure.” My doctor had instructed me to ...

Obese white men are about half as likely as normal-weight white men to have a total PSA level of 4 ng/mL or higher, a commonly used criterion for recommending a prostate biopsy, according to ...

Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC ...

During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.